vs

Side-by-side financial comparison of POWER SOLUTIONS INTERNATIONAL, INC. (PSIX) and Tarsus Pharmaceuticals, Inc. (TARS). Click either name above to swap in a different company.

POWER SOLUTIONS INTERNATIONAL, INC. is the larger business by last-quarter revenue ($191.2M vs $151.7M, roughly 1.3× Tarsus Pharmaceuticals, Inc.). POWER SOLUTIONS INTERNATIONAL, INC. runs the higher net margin — 8.4% vs -5.5%, a 13.9% gap on every dollar of revenue. On growth, Tarsus Pharmaceuticals, Inc. posted the faster year-over-year revenue change (128.4% vs 32.5%). Tarsus Pharmaceuticals, Inc. produced more free cash flow last quarter ($13.0M vs $-7.6M). Over the past eight quarters, Tarsus Pharmaceuticals, Inc.'s revenue compounded faster (134.4% CAGR vs 41.7%).

Adani Energy Solutions Ltd, formerly known as Adani Transmission Ltd, is an electric power transmission and distribution company headquartered in Ahmedabad. As of April 2025, the company operates a cumulative transmission network of 26,696 circuit kilometers and is one of the largest private sector power transmission companies operating in India.

Tarsus Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative therapeutic candidates for unmet medical needs in ophthalmology, dermatology, and other specialty care areas. It operates primarily in the United States, with lead product candidates targeting common, underdiagnosed conditions including demodex blepharitis and rosacea.

PSIX vs TARS — Head-to-Head

Bigger by revenue
PSIX
PSIX
1.3× larger
PSIX
$191.2M
$151.7M
TARS
Growing faster (revenue YoY)
TARS
TARS
+95.9% gap
TARS
128.4%
32.5%
PSIX
Higher net margin
PSIX
PSIX
13.9% more per $
PSIX
8.4%
-5.5%
TARS
More free cash flow
TARS
TARS
$20.6M more FCF
TARS
$13.0M
$-7.6M
PSIX
Faster 2-yr revenue CAGR
TARS
TARS
Annualised
TARS
134.4%
41.7%
PSIX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PSIX
PSIX
TARS
TARS
Revenue
$191.2M
$151.7M
Net Profit
$16.1M
$-8.4M
Gross Margin
21.9%
Operating Margin
12.7%
-5.3%
Net Margin
8.4%
-5.5%
Revenue YoY
32.5%
128.4%
Net Profit YoY
-31.0%
63.8%
EPS (diluted)
$0.69
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PSIX
PSIX
TARS
TARS
Q4 25
$191.2M
$151.7M
Q3 25
$203.8M
$118.7M
Q2 25
$191.9M
$102.7M
Q1 25
$135.4M
$78.3M
Q4 24
$144.3M
$66.4M
Q3 24
$125.8M
$48.1M
Q2 24
$110.6M
$40.8M
Q1 24
$95.2M
$27.6M
Net Profit
PSIX
PSIX
TARS
TARS
Q4 25
$16.1M
$-8.4M
Q3 25
$27.6M
$-12.6M
Q2 25
$51.2M
$-20.3M
Q1 25
$19.1M
$-25.1M
Q4 24
$23.3M
$-23.1M
Q3 24
$17.3M
$-23.4M
Q2 24
$21.5M
$-33.3M
Q1 24
$7.1M
$-35.7M
Gross Margin
PSIX
PSIX
TARS
TARS
Q4 25
21.9%
Q3 25
23.9%
Q2 25
28.2%
Q1 25
29.7%
Q4 24
29.9%
Q3 24
28.9%
Q2 24
31.8%
Q1 24
27.0%
Operating Margin
PSIX
PSIX
TARS
TARS
Q4 25
12.7%
-5.3%
Q3 25
13.9%
-12.2%
Q2 25
16.9%
-21.6%
Q1 25
18.2%
-33.5%
Q4 24
17.5%
-36.8%
Q3 24
16.3%
-52.3%
Q2 24
22.9%
-81.6%
Q1 24
11.2%
-136.5%
Net Margin
PSIX
PSIX
TARS
TARS
Q4 25
8.4%
-5.5%
Q3 25
13.5%
-10.6%
Q2 25
26.7%
-19.8%
Q1 25
14.1%
-32.1%
Q4 24
16.1%
-34.8%
Q3 24
13.8%
-48.7%
Q2 24
19.5%
-81.6%
Q1 24
7.5%
-129.4%
EPS (diluted)
PSIX
PSIX
TARS
TARS
Q4 25
$0.69
$-0.17
Q3 25
$1.20
$-0.30
Q2 25
$2.22
$-0.48
Q1 25
$0.83
$-0.64
Q4 24
$1.01
$-0.57
Q3 24
$0.75
$-0.61
Q2 24
$0.94
$-0.88
Q1 24
$0.31
$-1.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PSIX
PSIX
TARS
TARS
Cash + ST InvestmentsLiquidity on hand
$41.3M
$417.3M
Total DebtLower is stronger
$96.6M
$72.4M
Stockholders' EquityBook value
$178.6M
$343.4M
Total Assets
$424.7M
$562.2M
Debt / EquityLower = less leverage
0.54×
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PSIX
PSIX
TARS
TARS
Q4 25
$41.3M
$417.3M
Q3 25
$49.0M
$401.8M
Q2 25
$49.5M
$381.1M
Q1 25
$50.0M
$407.9M
Q4 24
$55.3M
$291.4M
Q3 24
$40.5M
$317.0M
Q2 24
$28.8M
$323.6M
Q1 24
$33.1M
$298.5M
Total Debt
PSIX
PSIX
TARS
TARS
Q4 25
$96.6M
$72.4M
Q3 25
$96.7M
$72.3M
Q2 25
$1.8M
$72.1M
Q1 25
$1.0M
$72.0M
Q4 24
$184.0K
$71.8M
Q3 24
$238.0K
$71.7M
Q2 24
$292.0K
$71.6M
Q1 24
$345.0K
$29.9M
Stockholders' Equity
PSIX
PSIX
TARS
TARS
Q4 25
$178.6M
$343.4M
Q3 25
$162.5M
$335.1M
Q2 25
$135.7M
$332.6M
Q1 25
$84.3M
$342.5M
Q4 24
$65.3M
$224.5M
Q3 24
$42.1M
$237.5M
Q2 24
$24.8M
$252.2M
Q1 24
$3.2M
$275.2M
Total Assets
PSIX
PSIX
TARS
TARS
Q4 25
$424.7M
$562.2M
Q3 25
$458.9M
$534.6M
Q2 25
$437.7M
$495.0M
Q1 25
$372.7M
$500.8M
Q4 24
$328.2M
$377.0M
Q3 24
$339.1M
$376.3M
Q2 24
$307.6M
$376.8M
Q1 24
$286.8M
$349.3M
Debt / Equity
PSIX
PSIX
TARS
TARS
Q4 25
0.54×
0.21×
Q3 25
0.60×
0.22×
Q2 25
0.01×
0.22×
Q1 25
0.01×
0.21×
Q4 24
0.00×
0.32×
Q3 24
0.01×
0.30×
Q2 24
0.01×
0.28×
Q1 24
0.11×
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PSIX
PSIX
TARS
TARS
Operating Cash FlowLast quarter
$-4.6M
$19.3M
Free Cash FlowOCF − Capex
$-7.6M
$13.0M
FCF MarginFCF / Revenue
-4.0%
8.6%
Capex IntensityCapex / Revenue
1.6%
4.2%
Cash ConversionOCF / Net Profit
-0.29×
TTM Free Cash FlowTrailing 4 quarters
$14.1M
$-22.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PSIX
PSIX
TARS
TARS
Q4 25
$-4.6M
$19.3M
Q3 25
$3.3M
$18.3M
Q2 25
$16.7M
$-29.4M
Q1 25
$8.8M
$-20.7M
Q4 24
$32.7M
$-22.2M
Q3 24
$12.6M
$-8.7M
Q2 24
$1.5M
$-14.4M
Q1 24
$15.6M
$-37.8M
Free Cash Flow
PSIX
PSIX
TARS
TARS
Q4 25
$-7.6M
$13.0M
Q3 25
$1.7M
$16.3M
Q2 25
$14.6M
$-30.4M
Q1 25
$5.4M
$-21.2M
Q4 24
$30.0M
$-22.3M
Q3 24
$12.1M
$-8.9M
Q2 24
$822.0K
$-15.4M
Q1 24
$14.8M
$-38.0M
FCF Margin
PSIX
PSIX
TARS
TARS
Q4 25
-4.0%
8.6%
Q3 25
0.8%
13.8%
Q2 25
7.6%
-29.6%
Q1 25
4.0%
-27.1%
Q4 24
20.8%
-33.5%
Q3 24
9.7%
-18.6%
Q2 24
0.7%
-37.8%
Q1 24
15.6%
-137.5%
Capex Intensity
PSIX
PSIX
TARS
TARS
Q4 25
1.6%
4.2%
Q3 25
0.8%
1.6%
Q2 25
1.1%
1.0%
Q1 25
2.5%
0.8%
Q4 24
1.8%
0.1%
Q3 24
0.3%
0.6%
Q2 24
0.6%
2.5%
Q1 24
0.9%
0.6%
Cash Conversion
PSIX
PSIX
TARS
TARS
Q4 25
-0.29×
Q3 25
0.12×
Q2 25
0.33×
Q1 25
0.46×
Q4 24
1.40×
Q3 24
0.73×
Q2 24
0.07×
Q1 24
2.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PSIX
PSIX

Energy End Market$153.4M80%
Industrial End Market$33.3M17%
Transportation End Market$4.6M2%

TARS
TARS

Segment breakdown not available.

Related Comparisons